Cell Therapeutics targeting potential Zevalin label expansion.

With potential authorization of OPAXIO and pixantrone in ’09 2009, and potential sales income growth due to possible Zevalin label expansion, we are on target to perform our goal of reaching cashflow break-even in the fourth quarter of 2009, Bianco added. Targeted 2009 Milestones: ZEVALIN – – First – collection consolidation indication authorization for Zevalin with a target decision day by the FDA of April 2, 2009, predicated on a supplemental biologics permit program submitted on October 2, 2008 for the usage of Zevalin as consolidation therapy after remission induction in previously untreated individuals with follicular non-Hodgkin’s lymphoma.Growers. ‘It’s good news, late in the process. It’s an announcement they must have made some days ago,’ stated John McClung of the Texas Generate Association. He called the caution too broad still, because many peppers from Mexico are grown on farms in areas not implicated. Simultaneously, investigators from the Centers for Disease Control and Prevention are retracing the probe’s early measures to see if jalapenos were skipped in early stages – or if tomatoes do indeed play a role.